SEC 8-K filings, classified by Claude with reasoning. Ingested in near-real time from EDGAR's filing stream, reconciled overnight.
Material 8-K events ordered by the time EDGAR accepted them. New filings appear at the top automatically — no refresh needed. Only filings ingested in near-real-time appear here; the daily-index reconciliation backstop fills in the catalog overnight, but those rows don't carry a sub-day timestamp and land on the Latest view instead.
ISQ Open Infrastructure entered into a $60 million revolving credit facility (expandable to $180 million) on June 11, 2026, creating a direct financial obligation with customary covenants and events of default.
View raw filing on EDGAR →XCF Global terminated a $50 million equity purchase agreement with Helena Global Investment Opportunities I LTD. that had reserved approximately 55 million shares for potential issuance. While the termination itself eliminates dilution risk, the core event disclosed is the unwinding of a dilutive equity arrangement that previously posed material overhang and dilution concerns. The filing emphasizes the reduction in "potential dilution and associated market overhang," indicating this was a material equity issuance arrangement.
View raw filing on EDGAR →The 8-K discloses results of Biofrontera's Annual Meeting of Stockholders held on June 11, 2026, under Item 5.07. The filing reports three matters voted on: election of two Class II directors (Beth J. Hoffman, Ph.D. and Kevin D. Weber), approval of an amendment to the 2021 Omnibus Incentive Plan increasing authorized shares from 3.75M to 8.75M, and ratification of CBIZ CPAs P.C. as independent auditor. These are routine but material shareholder votes affecting governance and equity authorization.
View raw filing on EDGAR →The filing discloses a letter agreement with Stavros Vizirgianakis, the Chairman, in connection with his appointment as Executive Chairman. The material substance is the Board's approval of a 450,000 RSU grant under the 2023 Share Incentive Plan with a three-tranche vesting schedule. While the appointment itself is mentioned, the filing centers on the compensatory arrangement—the equity grant—which is the principal disclosed action and would materially affect investor assessment of executive compensation and dilution.
View raw filing on EDGAR →The filing discloses results of the Company's 2026 Annual Meeting of Shareholders held on June 11, 2026, with voting outcomes on four proposals: election of four directors, ratification of the independent auditor (CBIZ CPAs P.C.), advisory approval of named executive officer compensation, and approval of an amendment to the Equity Incentive Plan increasing authorized shares by 1,750,000. Item 5.07 explicitly presents detailed voting tallies for each proposal, which is the core disclosure required for shareholder vote results under the 8-K taxonomy.
View raw filing on EDGAR →Karen Hawkins, Chief Financial Officer and Secretary of Optex Systems Holdings, Inc., notified the Company on June 12, 2026 of her intention to resign effective December 31, 2026. The departure of a CFO is a material executive change that would affect a reasonable investor's assessment of the registrant's financial leadership and continuity. The filing explicitly states no disagreements or accounting issues were involved, confirming this is a straightforward departure disclosure.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the certified results of Alector's 2026 annual meeting of stockholders held on June 17, 2026, including voting outcomes for three proposals: election of Class II directors (Elizabeth Garofalo, Errol De Souza, and Kristine Yaffe), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents vote tallies (for, against, abstentions, broker non-votes) for each matter, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →Outset Medical entered into a material amendment to its purchasing agreement with HCA on June 14, 2026, committing HCA to purchase approximately $40 million in new Tablo Hemodialysis Systems from 2026 through 2028, representing a significant multi-year commercial commitment affecting the company's revenue pipeline.
View raw filing on EDGAR →The Board unanimously approved submitting governance proposals to stockholders to eliminate the classified board structure and all supermajority voting provisions in the Articles of Incorporation. This represents a material change to corporate governance structure that would affect shareholder voting rights and director election processes. While not fitting neatly into the specific event categories (it is not a shareholder vote result, but rather a proposal for one), the elimination of classified boards and supermajority voting provisions is material to investors' assessment of governance and control dynamics.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from AEON Biopharma's Annual Meeting of Stockholders held on June 17, 2026. The filing reports the final certified voting results for two proposals: (1) election of Class III directors Marc Forth and Seongsoo Park for three-year terms, and (2) ratification of KPMG LLP as independent auditor. Director elections and auditor ratifications are material governance matters affecting investor confidence in board composition and financial oversight.
View raw filing on EDGAR →Workhorse entered into Omnibus Amendment No. 2 on June 16, 2026, materially restructuring its credit facilities with MGMH by increasing the Cash Flow Credit Agreement commitment from $20M to $30M, deferring interest payments on the additional $10M tranche, reducing the Customer Order Credit Agreement from $30M to $20M, and obligating issuance of warrants as consideration. This material restructuring of debt facilities, commitment reallocation, and dilutive warrant issuance constitute a material change in the Company's capital structure and financial obligations.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Mastercard's June 16, 2026 annual meeting of stockholders, including votes on director elections (11 nominees), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as auditor, and two shareholder proposals. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each matter are the core content, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and governance outcomes.
View raw filing on EDGAR →Kforce entered into a Rule 10b5-1 stock trading plan on June 15, 2026 to repurchase its own common stock under a Board-authorized share repurchase program. While share buybacks are generally material corporate actions affecting capital allocation and shareholder value, this disclosure does not fit neatly into the more specific event categories (it is not a dilutive issuance, M&A activity, or executive compensation). The filing is material because it signals the Firm's intent to return capital and reflects management's confidence in the stock, but the event type is best classified as "other_material" given the absence of a dedicated taxonomy entry for routine buyback plan adoptions.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the certified results of Roku's June 11, 2026 annual meeting of stockholders, including voting outcomes on three proposals: election of Class III directors (Jeffrey Hastings, Neil Hunt, Anthony Wood), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies with percentages in favor for each matter, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →The filing discloses a notice of delinquency from NYSE Regulation on May 19, 2026, for failure to timely file the Form 10-Q, triggering Section 1007 procedures and subjecting the Company to potential suspension and delisting. Although the Company subsequently filed the Form 10-Q on June 12, 2026, and regained compliance by June 15, 2026, the core event disclosed under Item 3.01 is the delisting risk and the Company's path through the compliance remediation process. This is material to investors as it reflects a serious breach of listing standards and the threat of delisting, even though the immediate risk was cured before the 8-K filing date.
View raw filing on EDGAR →Mountain Crest announced the commencement of separate trading of ordinary shares and rights previously bundled in units, effective June 22, 2026, with new NASDAQ ticker symbols ("MCAH" and "MCAHR"). This is a material structural change affecting how the Company's securities trade and how investors can hold the underlying components, but it does not fit neatly into the more specific event categories (it is not an earnings release, executive change, M&A activity, impairment, or other defined event type). Classified as other_material because it is a material disclosure affecting the total mix of information available to investors regarding the Company's capital structure and trading mechanics.
View raw filing on EDGAR →Simulations Plus entered into an Agreement and Plan of Merger whereby the company will be acquired by SP Evolution HoldCo II, LLC (an Altaris affiliate) for $18.50 per share in an all-cash transaction. The merger agreement details consideration, closing conditions, financing commitments, and termination provisions.
View raw filing on EDGAR →The Board elected Roelof Botha as an independent director effective immediately to fill an existing vacancy, and appointed him to the Audit Committee. The disclosure centers on the appointment of a new director with significant public company and audit committee experience, making this a clear exec_appointment event. The related family employment disclosure and indemnification agreement are ancillary to the principal action of taking a board role.
View raw filing on EDGAR →The Company entered into a Securities Purchase Agreement to issue 15,000,000 shares of common stock for $3,750,000 in proceeds to three investors. This is a private placement of unregistered equity securities, which is a classic dilutive issuance event. The substantial share count and capital raise would materially affect a reasonable investor's assessment of ownership dilution and the company's financing strategy.
View raw filing on EDGAR →The filing discloses Compensation Committee approval of annual base salary adjustments for three named executives: Louis Hoch (CEO) at $995,000, Greg Carter (SVP, Chief Accounting Officer) at $325,000, and Michael White (SVP, Chief Accounting Officer) at $260,000, all effective August 3, 2026. This is a direct disclosure of compensatory arrangements under Item 5.02(e), which is material to investors assessing executive compensation practices.
View raw filing on EDGAR →The filing discloses adoption of new forms of equity award agreements (RSU, stock option, and common stock agreements) under the 2021 Incentive Award Plan and grants of time-based RSUs to three named executive officers (Dave Lillis, Jeff Mayfield, and Ryan Salmons) totaling approximately $319,636 in aggregate grant-date fair value. Item 5.02(e) explicitly identifies these as "material compensatory arrangements," and the disclosure details vesting structures, fair values, and vesting commencement dates for each executive.
View raw filing on EDGAR →Enterprise Financial Services Corp completed a $175 million issuance of subordinated notes on June 17, 2026, pursuant to a registered offering under Form S-3, creating material direct financial obligations and expanding the company's capital structure.
View raw filing on EDGAR →Hozefa Lokhandwala was appointed as Executive Vice President and Chief Financial Officer effective June 16, 2026, with a base salary of $750,000, target bonus of 100%, annual equity grants of $750,000, and severance provisions.
View raw filing on EDGAR →AMC Global Media held its annual meeting of stockholders on June 16, 2026, with voting results disclosed on four proposals: election of Class A and Class B directors, ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the Amended and Restated 2011 Stock Plan for Non-Employee Directors.
View raw filing on EDGAR →Stockholders approved three proposals at the Annual Meeting held on June 16, 2026: election of five directors (David Moss, J. Kelly Ganjei, Tim Schroeder, Scott Juda, and Marcia Allen), ratification of CBIZ CPAs P.C. as independent auditors, and approval of the Third Amended and Restated 2021 Stock Incentive Plan with increased reserved shares and an evergreen provision.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the June 12, 2026 Annual Meeting of Stockholders, covering three proposals: election of three Class I directors (Michael Singer, Timothy Springer, and Patrick Zenner), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The filing explicitly states the vote tallies and outcomes for each proposal, which is the core content of Item 5.07.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Forward Air Corporation's annual stockholder meeting held on June 17, 2026, including voting outcomes on four proposals: election of five directors, advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditor, and approval of an amendment to the 2025 Omnibus Incentive Compensation Plan. The filing presents vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes on four proposals at the 2026 Annual Meeting held June 17, 2026: election of two Class III directors (Michael Landsittel and Cameron Turtle), Say-on-Pay advisory vote, Say-on-Frequency advisory vote, and auditor ratification. All proposals passed with strong majorities, and the Board determined to hold annual Say-on-Pay votes based on the voting results.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on June 16, 2026, filed under Item 5.07. The filing reports voting outcomes on four matters: election of three Class A directors (Rod Baltzer, Renee Hornbaker, Christa Steele), ratification of CBIZ CPAs as independent auditor, advisory vote on executive compensation, and advisory vote on frequency of future compensation votes. All proposals passed with disclosed vote tallies and quorum information (60.13% attendance).
View raw filing on EDGAR →Liberty Star entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC to issue a $73,700 convertible promissory note with 10% Original Issue Discount, convertible into common stock. This is a dilutive issuance of equity securities (via conversion rights embedded in the convertible note), a material financing event for a small-cap uranium exploration company that signals capital-raising pressure and future shareholder dilution.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on June 11, 2026. The filing reports final vote tallies for all five proposals, including director elections, executive compensation advisory vote, stock plan approval, certificate amendment, and auditor ratification. Item 5.07 is the designated 8-K item for shareholder vote results, and the detailed voting data with percentages and broker non-votes confirms this classification.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of ATN International's Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting tallies for three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →This disclosure describes the entry into multiple material definitive agreements in connection with the issuance and sale of asset-backed securities (Notes) on June 17, 2026. The core transaction involves a Receivables Purchase Agreement whereby HCA transferred retail installment sale contracts to HABS, followed by a Sale and Servicing Agreement transferring those receivables to a trust that issued the Notes. This constitutes a material securitization transaction—a form of asset disposition and financing activity that would materially affect the registrant's financial position and capital structure.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Oak Valley Bancorp's Annual Meeting of Shareholders held June 16, 2026. Item 5.07 explicitly requires disclosure of voting results on matters submitted to security holders. The filing reports votes on two matters: (1) re-election of four board members (Christopher M. Courtney, Lynn R. Dickerson, Allison C. Lafferty, and Terrance P. Withrow), and (2) ratification of RSM US LLP as the independent auditor. Board elections and auditor ratification are material governance matters affecting investor confidence in the company's oversight and financial reporting.
View raw filing on EDGAR →Potomac Electric Power Company entered into a Bond Purchase Agreement on March 19, 2026, and issued $300 million in aggregate principal amount of First Mortgage Bonds across three series (5.00%, 5.30%, and 5.74%) on June 17, 2026. This material debt financing transaction affects the registrant's capital structure and financial obligations.
View raw filing on EDGAR →American Express issued €750 million of senior notes on June 17, 2026, a material debt issuance that affects the company's capital structure and financial obligations. While this is a routine debt offering disclosed under Item 8.01, it does not fit neatly into the more specific event categories (it is not M&A, not a covenant breach, not a restatement, etc.), making "other_material" the most appropriate classification for a significant financing event.
View raw filing on EDGAR →The Board of Directors elected Brent McRae as President on June 15, 2026. This is a clear appointment of an officer to a principal executive role. The disclosure focuses on the election/appointment action and McRae's relevant background in cooperative governance, making this an executive appointment event material to investors assessing leadership changes.
View raw filing on EDGAR →Shane Tackett was elected as president of Alaska Airlines effective June 29, 2026. The appointment also included compensatory arrangements including a salary increase to $692,804, increased cash incentive target to 105% of base salary, and a $3,000,000 long-term incentive award target.
View raw filing on EDGAR →AbCellera announced a preclinical research collaboration and option/license agreement for T-cell engaging multispecific antibodies targeting GI cancers and solid tumors. While this represents a material strategic partnership leveraging the company's core antibody discovery platform, it does not fit cleanly into more specific event categories (not an M&A transaction, not an earnings release, not an executive change). The disclosure would affect a reasonable investor's assessment of the company's pipeline and strategic direction, warranting material classification under "other_material."
View raw filing on EDGAR →Southern Copper priced a $1.25 billion senior unsecured notes offering at 5.350% due 2036. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financing activities, it does not fit cleanly into the more specific event categories (it is not a dilutive equity issuance, M&A activity, or other defined event type). The disclosure of a substantial debt offering under Item 8.01 warrants classification as a material event outside the standard taxonomy.
View raw filing on EDGAR →Lakewood-Amedex Biotherapeutics approved and implemented a 1-for-10 reverse stock split, effective June 19, 2026, which was filed with the Nevada Secretary of State. This structural capital event materially modifies the rights of security holders by reducing share count and affecting trading mechanics and investor holdings.
View raw filing on EDGAR →